NeoVac Ltd was incorporated in September 2021 and is registered at Suites 1 And 2 127 Olympic Avenue, Abingdon, OX14 4SA. The company is active and classified under SIC code 72110 for research and experimental development on biotechnology. That classification places it in the biotechnology sector, where companies typically conduct laboratory research, develop new biological products, and work on innovations in areas such as pharmaceuticals, diagnostics, and medical therapies. The company name suggests a focus on vaccine development, but this cannot be confirmed from public records alone. As a registered sponsor on the Skilled Worker route with an A rating, NeoVac Ltd is authorised to employ overseas workers. This indicates that the company has met the Home Office's requirements for sponsorship and is actively participating in the visa system. The A rating is the standard rating for most sponsors, meaning it holds a valid licence and has not had it revoked or downgraded. Given its relatively recent incorporation, NeoVac Ltd is likely a small enterprise, possibly a startup. Small biotech firms of this kind often rely on a mix of grant funding, partnerships, and external investment. The absence of publicly available web content means details about its specific projects, team size, or commercial partnerships are not accessible. Its activities are consistent with a research-focused firm rather than a large manufacturer. For job seekers considering sponsorship, the sponsor licence is a positive signal. However, without additional information about current vacancies, the extent of its hiring activity remains unknown. Researchers examining sponsor legitimacy can confirm that NeoVac Ltd is properly registered with Companies House and holds a valid sponsor licence.

NeoVac Ltd was incorporated in September 2021 and is registered at Suites 1 And 2 127 Olympic Avenue, Abingdon, OX14 4SA. The company is active and classified under SIC code 72110 for research and experimental development on biotechnology. That classification places it in the biotechnology sector, where companies typically conduct laboratory research, develop new biological products, and work on innovations in areas such as pharmaceuticals, diagnostics, and medical therapies. The company name suggests a focus on vaccine development, but this cannot be confirmed from public records alone. As a registered sponsor on the Skilled Worker route with an A rating, NeoVac Ltd is authorised to employ overseas workers. This indicates that the company has met the Home Office's requirements for sponsorship and is actively participating in the visa system. The A rating is the standard rating for most sponsors, meaning it holds a valid licence and has not had it revoked or downgraded. Given its relatively recent incorporation, NeoVac Ltd is likely a small enterprise, possibly a startup. Small biotech firms of this kind often rely on a mix of grant funding, partnerships, and external investment. The absence of publicly available web content means details about its specific projects, team size, or commercial partnerships are not accessible. Its activities are consistent with a research-focused firm rather than a large manufacturer. For job seekers considering sponsorship, the sponsor licence is a positive signal. However, without additional information about current vacancies, the extent of its hiring activity remains unknown. Researchers examining sponsor legitimacy can confirm that NeoVac Ltd is properly registered with Companies House and holds a valid sponsor licence.